跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PHEBRA SODIUM SELENATE DECAHYDRATE 467 microgram/2mL injection vial - TGA Drug Approval Details
Approvals
/
TGA
/
PHEBRA SODIUM SELENATE DECAHYDRATE 467 microgram/2mL injection vial
Approved
STANDARD
PHEBRA SODIUM SELENATE DECAHYDRATE 467 microgram/2mL injection vial
Phebra Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
dd46e184ed427681
Company
Phebra Pty Ltd
Type
Standard
Approval Details
Approval Id
dd46e184ed427681
Product Name
PHEBRA SODIUM SELENATE DECAHYDRATE 467 microgram/2mL injection vial
Artg Id
22868
Artg Name
PHEBRA SODIUM SELENATE DECAHYDRATE 467 microgram/2mL injection vial
Sponsor
Phebra Pty Ltd
Company Detail Path
/organization/phebra-pty-ltd
Artg Date
1991-10-14
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/e096d80a310f10339afa3f274efe9835.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/b2e5883212f28bf0fab110acc403484d.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
dd46e184ed427681
Type
Standard
Back to TGA Approvals
